---
title: "China Resources Pharmaceutical Group Limited (03320.HK)｜Company Overview"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/03320.HK/overview.md"
symbol: "03320.HK"
name: "China Resources Pharmaceutical Group Limited"
parent: "https://longbridge.com/en/quote/03320.HK.md"
datetime: "2026-10-12T12:49:34.901Z"
locales:
  - [en](https://longbridge.com/en/quote/03320.HK/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/03320.HK/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/03320.HK/overview.md)
generator: "portal-rs"
---

# China Resources Pharmaceutical Group Limited (03320.HK) — Company Overview

## Basic Information

| Item | Detail |
| --- | --- |
| Industry | Pharmaceuticals |
| Exchange | HK Market |
| Address | China Resources Building, 41st Floor, Room 4104–05, 26 Harbour Road, Wan Chai, Hong Kong |
| Website | [www.crpharm.com](https://www.crpharm.com) |

## Company Profile

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular, metabolism, intravenous infusion, and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies.

## Key Executives

| Name | Title |
| --- | --- |
| Xiaosong Bai | Executive Chairman of the Board |
| Jie Cheng | President & Executive Director |
| Rong Deng | Chief Financial Officer |
| Changan Liu | Executive Director |
| Yanwei Huang | CFO of CR Jiangzhong |
| Kai Qiu | VP & Chairman of China Resources Boya |
| Tingmei Fu | Independent Non-Executive Director |

## Major Shareholders

| Name | Ratio | Report Date |
|------|-------|-------------|
| China Resources Company Limited | 53.40% | 2025-12-31 |
| Beijing State-owned Capital Operation and Management Company Limited | 17.43% | 2025-12-31 |
| Vanguard Capital Management, LLC | 1.22% | 2026-08-31 |
| BlackRock, Inc. | 0.53% | 2026-09-30 |
| Dimensional Fund Advisors LP | 0.52% | 2026-09-30 |
| Causeway Capital Management LLC | 0.33% | 2026-06-30 |
| Norges Bank Investment Management | 0.31% | 2026-06-30 |
| E Fund Management Co., Ltd. | 0.25% | 2025-12-31 |
| China Asset Management Co. Ltd. | 0.21% | 2026-09-02 |
| JP Morgan Asset Management | 0.18% | 2026-09-30 |

## Business Breakdown

| Segment | Revenue | Ratio |
| --- | --- | --- |
| Distribution | 220080370000 | 77.65% |
| Manufacturing | 51038542000 | 18.01% |
| Retail | 12210359000 | 4.31% |
| Others | 93249000 | 0.03% |
| Elimination of Inter-Segment Sales | -13848194000 | % |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "data": {
    "values": [
      {
        "ratio": 77.65,
        "segment": "Distribution"
      },
      {
        "ratio": 18.01,
        "segment": "Manufacturing"
      },
      {
        "ratio": 4.31,
        "segment": "Retail"
      },
      {
        "ratio": 0.03,
        "segment": "Others"
      },
      {
        "ratio": 0.0,
        "segment": "Elimination of Inter-Segment Sales"
      }
    ]
  },
  "encoding": {
    "color": {
      "field": "segment",
      "type": "nominal"
    },
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    }
  },
  "mark": "arc",
  "title": "China Resources Pharmaceutical Group Limited Business Breakdown"
}
```

## Geographic Segments

| Region | Revenue | Ratio |
|--------|---------|-------|
| Mainland China | 268506044000 | 99.6% |
| Others | 1068282000 | 0.4% |


---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**